Division of Hematology and Oncology: Department of Medicine: Feinberg School of Medicine: Northwestern University

The Division of Hematology and Oncology is focused on improving patients’ therapeutic options and quality of life while working to better prevent, diagnose and treat cancer and hematologic disorders.

“Our division houses laboratory-based investigators focused on a broad array of topics, including chemoprevention, cell signal pathways, epigenetics, immune-modulation, and nanotechnology theranostics.”

– William J. Gradishar, MD

Read Message from the Chief

What We Do

Education

Learn More

Research

Learn More

Patient Care

Cancer Care

Faculty: Meet the Team

View individual profiles of our faculty members and learn about their research and clinical specialties.

See All Faculty

Leonidas C Platanias

Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics

chronic leukemias, multiple myeloma, non-hodgkin's lymphoma

Hau C Kwaan

Professor of Medicine (Hematology and Oncology)

Hematology and Oncology, with special interest in Thrombosis and Bleeding Disorders and in Fibrinolysis.

Sheetal M Kircher

Associate Professor of Medicine (Hematology and Oncology)

My clinical interests include treating gastrointestinal malignancies. My research interests are on improving the quality of cancer care and better understanding the trends in use and expenditure of services and drugs. I am also interested in evaluation of cancer-related health policies.

William J Gradishar

Professor of Medicine (Hematology and Oncology)

My clinical domain is breast cancer management. My clinical research interest focuses on the development of novel therapies for the treatment of breast cancer. Clinical trials focusing on precision medicine for defining the right therapy, for the right patient at the right time is our goal. To that end, molecular interogation of breast tumors are leading to novel trial design that will hopefully translate into better outcomes for our patients. In conjuction with the developmental therapeutics program, novel agents are being incorporated into clinical trials for patients with both early and lat...

Jeffrey A Sosman

Professor of Medicine (Hematology and Oncology)

I have been an active clinical investigator vested in the immune-based therapy of melanoma. This has led to my role in the clinical development of initially Interleukin-2 and more recently anti-CTLA-4 and anti-PD1/PDL-1. While checkpoint therapy has been a great breakthrough in cancer treatment, additional immune-based strategies are still critically needed. Efforts to identify mechanisms of resistance to checkpoint inhibitors and approaches to overcome de novo and acquired resistance are one of my major interest. In addition I have ongoing efforts in the personalized therapy of melanoma with ...

Jayesh Mehta

Professor of Medicine (Hematology and Oncology)

Myeloma, Transplantation

Marcus Ernst Peter

Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics

The lab of Dr. Marcus E. Peter studies various forms of cell death including apoptosis, which is a fundamental process to regulate homeostasis of all tissues and to eliminate unwanted cells specifically in the immune system. Another interest lies in the study of RNA interference and based on toxic RNAs to development a novel form of cancer treatment. The laboratory is located within the Robert H. Lurie Cancer Center at Northwestern University.

Maha H.A. Hussain

Professor of Medicine (Hematology and Oncology)

Maha Hussain, MD, FACP, FASCO, is the Genevieve Teuton Professor of Medicine in the Division of Hematology Oncology, Department of Medicine, and the Deputy Director at the Robert H. Lurie Comprehensive Cancer Center of the Northwestern University Feinberg School of Medicine. She is a practicing oncologist, internationally renowned expert and clinical researcher in genitourinary oncology particularly prostate and bladder cancer. Her clinical research has contributed to impacting the standards of care for patients with metastatic hormone sensitive and castration resistant prostate cancer. Prior ...

Curt M Horvath

Professor of Weinberg College of Arts and Sciences, Medicine (Hematology and Oncology) and Microbiology-Immunology

Interferon, STAT

Barbara Pro

Professor of Medicine (Hematology and Oncology)

Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Clinical trials

News

Driskill Day 2019: Achievements in Life Sciences

New Brain Cancer Drug Shows Promise

Faculty Explore Policy Solutions for Cancer Drug Delivery

Pancreatic Cancer Drug, High-Fat Diet Linked to Liver Disease Risk

More News

Events

The Under-recognized Translational Significant in Many Disorders,...

September 20
8:00 AM - 9:00 AM

Cancer and Physical Sciences (CAPS) Webinar: What is the Bionanop...

September 23
12:00 PM - 1:00 PM

Survive & Thrive - Ovarian Cancer Patient & Caregiver Program

September 28
9:00 AM - 5:00 PM

All Events

Contact Us

We welcome your questions and comments.

Learn More

Diversity and Inclusion

The department works toward an environment of inclusion and support through the Diversity and Cultural Affairs Council and through several dedicated events and initiatives.

Learn More

Housestaff Research Portal

Graduate Research Resources

We offer a wide range of resources, mentorship opportunities and training to help our residents and fellows excel as physician-scientists. Explore all of the resources and hear from housestaff who are making research a major part of their career development plans.

Visit the Housestaff Research Portal

Giving

Support What We Do

We invite your philanthropic partnership in helping us achieve our research and teaching missions each day.

Make an online donation

Contact Terri Dillon for more information on supporting the Division of Hematology-Oncology at 312-503-4837 or terri-dillon@northwestern.edu.